Ignite Creation Date:
2024-05-05 @ 7:54 PM
Last Modification Date:
2024-10-26 @ 9:55 AM
Study NCT ID:
NCT00760877
Status:
COMPLETED
Last Update Posted:
2016-11-08
First Post:
2008-09-25
Brief Title:
Nilotinib Versus Standard Imatinib 400600 mg Every Day QD Comparing the Kinetics of Complete Molecular Response for Chronic Myelogenous Leukemia in Chronic Phase CML-CP Pts With Evidence of Persistent Leukemia by Real-time Quantitative Polymerase Chain Reaction RQ-PCR
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-06
Start Date Type:
None
Primary Completion Date:
2015-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-07
Completion Date Type:
ACTUAL
First Submit Date:
2008-09-25
First Submit QC Date:
September 25 2008
Study First Post Date:
2008-09-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2016-08-16
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-10-04
Last Update Post Date:
2016-11-08
Last Update Post Date Type:
ESTIMATED